ReviewFrontiers in pharmacology2023

Anaplastic lymphoma kinase inhibitors-a review of anticancer properties, clinical efficacy, and resistance mechanisms.

Kajetan Kiełbowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.